Purdue’s Payouts
Oct 13, 2021
2 minutes
Julia Lurie and Ryan Little
Before it was dissolved this fall, Purdue Pharma made billions selling the painkillers behind the overdose crisis while giving millions to patient advocacy groups, doctors’ organizations, and academia—spending that effectively served as an OxyContin marketing blitz.
Yet the details of this largesse have long been murky. Congressional and media investigations have named only
You’re reading a preview, subscribe to read more.
Start your free 30 days